Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1995-03-31
1998-07-07
Sayala, Chhaya D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514 12, 514930, 514648, A61K 31195
Patent
active
057769796
ABSTRACT:
The present invention involves a method for prophylaxis or treatment of an animal for systemic hypotension induced by endotoxin and/or a biological response modifier such as the cytokines, IFN, TNF, IL-1 or IL-2 and the like. The method involves administering, preferably intravascularly, a therapeutically effective amount of dobutamine and an inhibitor of nitric oxide formation from arginine.
REFERENCES:
patent: 4282217 (1981-08-01), Baglioni et al.
patent: 5028627 (1991-07-01), Kilbourn et al.
patent: 5059712 (1991-10-01), Griffith
patent: 5312835 (1994-05-01), Kilbourn et al.
Bone, JAMA, vol. 266(12), pp. 1686-1691, 1991.
Vincent et al., Crit. Care Med., vol. 18(1), pp. 570-741 1990.
Kilbourn et al., Biochem. Biophy. Res Comm. vol. 172(3), pp. 1132-1138, 1990.
Kilbourn et al., PNAS, vol. 87, pp. 3629-3632, 1990.
Kilbourn et al., J: National Cancer Inst, vol. 84(13), pp. 1008-1016, 1992.
Gross et al., Biochem. Biopyh Res. Comm., vol. 178(3) pp. 823-829, 1991.
Sakuma, I. et al., (1988) "Identification of Arginine as a Precursor of Endothelium-Derived Relaxing Factor, " Proc. Natl. Acad. Sci. USA, 85:8664-8667, published in U.S.A.
Abstract entitled "Nitric Oxide Damages DNA in Bacteria," Chem. and Engineering News,Nov. 18, 1991, published in U.S.A.
Wink et al., (1991) "DNA Deaminating Ability and Genotoxicity of Nitric Oxide and its Progenitors," Science, 254:1001-1003, published in U.S.A.
Kilbourn et al., (1984) "Activated Macrophages Secrete a Soluble Factor that Inhibits Mithochondrial Respiration of Tumor Cells," J. Immunology, 133:2577-2581, published in U.S.A.
Kilbourn et al., (1990) "Reversal of Endotoxin-Mediated Shock by N.sup.g- Methyl-L-Arginine, an Inhibitor of Nitric Oxide Synthesis, " Biochem. and Biophys. Res. Commun., 172:1132-1138, published in U.S.A.
Kilbourn, R.G., et al., (1990) "N.sup.g- Methyl-L-Argingine Inhibits Tumor Necrosis Factor-Induced Hypotension: Implications for the Involvement of Nitric Oxide, " Proc. Natl. Acad. Sci. USA, 87:3629-3632, published in U.S.A.
Schmidt et al., (1992) "Insulin Secretion from Pancreatic B Cells Caused by L-Arginine-Derived Nitrogen Oxides," Science, 255:721-723, published in U.S.A.
Turan, A. et al., (1975) "Removal of the Nitro Group from Nitroarginine and Nirtroarginine Peptides," Acta Chimica Academiae Scientiarum Hungaricae, Tomas, 85:327-332, published in Europe.
Iyengar, R. et al., (1987) "Macrophage Synthesis of Nitrite, Nitrate, and N-Nitrosamines: Precursors and Role of the Respiratory Burst, " Proc. Natl. Acad. Sci. USA, 84:6369-6373, published in U.S.A.
Stueher et al., (1987) Induction of Nitrite/Nitrate Synthesis in Murine Macrophages by BCG Infection, Lymphokines, or Interferon-.gamma..sup.1 J. Immunology, 139:518-525, published in U.S.A.
Marletta et al., (1988 "Macrophage Oxidation of L-Arginine to Nitrite and Nitate: Nitric Oxide Is an Intermediate," Biochemistry, 27:8706-8711, published in U.S.A.
Palmer, R.M.J. et al., (1988) "Vascular Endothelial Cells Synthesize Nitric Oxide from L-Arginine," Nature, 333:664-666, published in the United Kingdom.
Palmer, R.M.J. et al. (1988) "L-Arginine is the Physiological Precursor for the Formation of Nitric Oxide in Endothelium-Dependent Relaxation," Biochem. Biophys. Res. Commun., 153:1251-1256, published in U.S.A.
Schmidt et al., (1988) "Arginine is a Physiological Precursor of Endothelium-Derived Nitric Oxide," European J. Pharmacology, 154:213-216, published in Europe.
Aisaka et al., (1989) "N.sup.G- Methylarginine , An Inhibitor of Endothelium-Derived Nitric Oxide Synthesis, Is a Potent Pressor Agent in the Guinea Pig: Does Nitric Oxide Regulate Blood Pressure in Vivo?" Biochem. Biophys. Res. Commun., 160:881-886, published in U.S.A.
Rees, D.D. et al., (1989) "Role of Endothelium-Derived Nitric Oxide in the Regulation of Blood Pressure," Proc. Natl. Acad. Sci. USA. 86:3375-3378, published in U.S.A.
Stuehr, D.J., et al., (1989) "Activated Murine Macrophages Secrete a Metabolite of Arginine with the Bioactivity of Endothelium-Derived Relaxing Factor and the Chemical Reactivity of Nitric Oxide," J. Exp. Med., 169:1011-1020, published in U.S.A.
Stuehr, D.J. et al., (1989) "Synthesis of Nitrogen Oxides from L-Arginine by Macrophage Cytosol: Requirement for Inducible and Constitutive Components," Biochem. Biophys. Res. Commun., 161:420-426, published in U.S.A.
Piguet et al., (1989) "Tumor Necrosis Factor/Cachectin Plays a Key Role in Bleomycin-Induced Pneumopathy and Fibrosis," J. Exp. Med., 170:655-663, published in U.S.A.
Kilbourn et al., (1990) "Endothelial Cell Production of Nitrogen Oxides in Response to Interferon .gamma. in Combination with Tumor Necrosis Factor, Interleukin-1, or Endotoxin " J. Natl. Cancer Institute, 82:772-776, published in U.S.A.
Gross et al. (1991) "Cytokine-Activated Endothelial Cells Express an Isotype of Nitric Oxide Synthase Which Is Tetrahydrobiopterin-Dependent, Calmodulin-Independent and Inhibited by Arginine Analogs with a Rank-Order of Potency Characteristic of Activated Macrophages," Biochem. Biophys. Res. Commun., 178:823-829, published in U.S.A.
Kilbourn et al., (1990) "Endothelial Cell Production of Nitrogen Oxides in Response to Interferon .gamma. in Combination with Tumor Necrosis Factor, Interleukin-1, or Endotoxin," J. Natl. Cancer Institute, 82(9):772-776, published in U.S.A.
Kilbourn et al., (1990) "N.sup.G -Methyl-L-Arginine Inhibits Tumor Necrosis Factor-Induced Hypotension: Implications for the Involvement of Nitric Oxide," Proc. Natl. Acad. Sci. U.S.A.., 87:3629-3632, published in U.S.A.
Gennaro, Alfonso R., Editor, and Chairman of the Editorial Board (1990) "Sympathomimetic Drugs ", Remington's-Pharmaceutical Sciences, 18th Edition, p. 877, published in U.S.A.
Windholz, Martha, Editor, (1983) "Dobutamine," The Merck Index, An Encyclopedia of Chemicals, Drugs, an Biologicals, Tenth Edition, 3407. p. 495, published in U.S.A.
Goodman and Gilman, "Catecholamines and Sympathomimetic Drugs," The Pharmacological Basis of Therapeutics, Eighth Edition , 1989, 202-203, 214-215, published in U.S.A.
Klabunde and Ritger, (1991), "N.sup.g- Monomethyl-L-Arginine (NMA) Restores Arterial Blood Pressure but Reduces Cardiac Output in a Canine Model of Endotoxic Shock," Biochemical and Biophysical Research Communications, 178(3) :1135-1140, published in U.S.A.
Klabunde, et al. (1991) , "Cardiovascular Actions of Inhibitors of Endothelium-Derived Relaxing Factor (Nitric Oxide) Formation/Release in Anesthetized Dogs," European Journal of Pharmacology, 199:51-59, published in the Netherlands.
Vincent, et al. (1990), "Dobutamine Administration in Septic Shock: Addition to a Standard Protocol," Critical Care Medicine, 18(7):689-693, published in U.S.A.
Vincent et al. (1990) "Septic Shock: Particular Type of Acute Circulatory Failure," Critical Care Medicine, 18(1) :S70-S74, published in U.S.A.
Shoemaker et al. (1990), "Therapy of Shock Based on Pathophysiology, Monitoring, and Outcome Prediction," Critical Care Medicine, 18(1) :S19-S25, published in U.S.A.
Schremmer et al.(1990). "Heart Failure in Septic Shock: Effects of Inotropic Support," Critical Care Medicine, 18(1) :S49-S55, published in U.S.A.
Moncada et al., "Nitric Oxide: Physiology, Pathophysiology, and Pharmacology," Pharmacological Reviews, 43(2):109-142, 1991, published in USA.
Moncada et al., "The L-Arginine: Nitric Oxide Pathway," Journal of Cardiovascular Pharmacology, 17(Suppl. 3) :S1-S9, 1991, published in USA.
Parratt, J.R., and Stoclet, Jean-Claude, "Possible Role of Nitric Oxide in Refractory Hypotension Associated with Sepsis and Endotoxaemia and with Multiple Organ Failure," Applied Cardiopulmonary Pathophysiology, 4:143-149, 1991, published in USA.
Johnston, Jeff, "Molecular Science Sets Its Sights On Septic Shock, " The Journal of NIH Research, 3:61-65, 1991, published in USA.
Moncada, S., and Higgs, E.A., "Endogenous Nitric Oxide: Physiology, Pathology and Clinical Relevance," European Journal of Clinical Investigation, 21:361-374, 1991, published in Europe.
Palmer et al., "Nitric Oxide Release Accounts for the Biological Activity of Endothelium-Derived Relaxin
Griffith Owen W.
Gross Steven S.
Kilbourn Robert G.
Board of Regents, The University Of Texus System
Cornell Research Foundation Inc.
Sayala Chhaya D.
LandOfFree
Method of use of cardiotonic drugs and inhibitors of nitric oxid does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of use of cardiotonic drugs and inhibitors of nitric oxid, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of use of cardiotonic drugs and inhibitors of nitric oxid will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1206497